Antibodies that specifically block the biological activity of a tumor antigen

Details for Australian Patent Application No. 2009321508 (hide)

Owner National Research Council of Canada Alethia Biotherapeutics Inc.

Inventors Tremblay, Gilles Bernard; Filion, Mario; Sulea, Traian

Agent FB Rice

Pub. Number AU-A-2009321508

PCT Pub. Number WO2010/060186

Priority 61/193,184 03.11.08 US; 61/213,666 30.06.09 US

Filing date 3 November 2009

Wipo publication date 3 June 2010

International Classifications

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/060186 Priority application(s): WO2010/060186

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009321514-Fifth wheel coupling

2009321503-Systems and methods for processing requests for proposals and managing inventory